Please login to the form below
Patent exclusivity
This page shows the latest Patent exclusivity news and features for those working in and with pharma, biotech and healthcare.
Amarin shares tumble following Vascepa patent loss
The patent ruling only applies to Vascepa’s US patent exclusivity, with Amarin clarifying that its patents elsewhere in the world still stand.
Latest news
-
UPDATED: Gilead drops remdesivir’s orphan drug designation
Gilead had maintained that at the time that it had filed for the designation – which awards companies with patent exclusivity for seven years – the coronavirus outbreak was nowhere near the level ... Along with patent exclusivity, orphan drug
-
China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir
Raises concerns over patent exclusivity in the country. UPDATED 5 MARCH 2020: BrightGene has since been censured by the Shanghai Stock Exchange (SSE) for making misleading claims and disclosing inaccurate information ... The news reflects a larger issue
-
Biologic patent exclusivity scrapped in new US trade deal
The negotiations between the US, Mexico and Canada have reached an agreement to scrap patent exclusivity for biologics, meaning that each country can determine its own rules. ... In the past, the US has pushed to have its exclusivity rules applied to
-
AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER
That initial finding damaged AbbVie’s hopes of growing sales of Rinvoq to offset the anticipated loss of Humira revenues to biosimilar competitors when it loses its patent exclusivity.
-
Amgen snaps up Celgene’s Otezla for $13.4bn
This includes Enbrel (boosted earlier this month by a successful defence of its US patent) and Amgevita, its Humira biosimilar, which is approved and already available in Europe and approved ahead ... The drug has patent exclusivity through at least 2028
UPDATED: Gilead drops remdesivir’s orphan drug designation
China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir
Biologic patent exclusivity scrapped in new US trade deal
AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER
Amgen snaps up Celgene’s Otezla for $13.4bn
More from news
Approximately 1 fully matching, plus 57 partially matching documents found.
Latest Intelligence
-
Piloting a route to the biosimilars opportunities in Europe
By 2019, more than 14 innovative biological products had lost their orphan designation market exclusivity, and by 2029 another 34 innovative biological products will join them. ... Once that formula’s patent and market exclusivity expires, competing
-
The impact of COVID-19 on clinical trials
Delays in clinical trials will also likely translate into delays in launch timelines, which may result in shorter periods of patent exclusivity post-launch and lower revenue forecasts.
-
Interview: Trevor Smith, Takeda
Major products were about to lose, or had just lost, their patent exclusivity.”. ... For Nycomed this meant loss of exclusivity (LOE) on its blockbuster gastroinestinal drug pantoprazole and the consequent need to reorganise its business.
Piloting a route to the biosimilars opportunities in Europe
The impact of COVID-19 on clinical trials
Interview: Trevor Smith, Takeda
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Three strategies for managing loss of exclusivity successfully
2. “Price decay after loss of brand exclusivity”. 3. These are just three headlines that come up when you Google “drug patent expiry”. ... 4. It’s no wonder “loss of exclusivity (LOE)” or “the patent cliff” is an ominous prospect for
-
Three strategies for managing loss of exclusivity successfully
Price decay after loss of brand exclusivity”. These are just three headlines that come up when you Google “drug patent expiry”. It’s no wonder “loss of exclusivity (LOE)” or “the ... Loss of exclusivity (LOE) is a natural milestone in a
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
-
Digital account director
-
Competitive
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Events Executive
-
Depending on Experience
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
- Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- BMS’ Q2 results beat expectations with strong performance across core therapy areas
- Amanda Pritchard becomes NHS England’s first female chief executive
- Understanding the ‘real world’ starts and ends with the patient
- Onyx Health Launch Creative Studio After Record Year
- BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Tonix Pharmaceuticals to develop TNX-102 for long COVID syndrome
- Migraine-friendly colours for the home
PMHub
Create Health
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
